High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin.

Autor: Huh, Gunn1 (AUTHOR), Ryu, Ji Kon1 (AUTHOR) jkryu@snu.ac.kr, Chun, Jung Won1 (AUTHOR), Kim, Joo Seong1 (AUTHOR), Park, Namyoung1 (AUTHOR), Cho, In Rae1 (AUTHOR), Paik, Woo Hyun1 (AUTHOR), Lee, Sang Hyub1 (AUTHOR), Kim, Yong-Tae1 (AUTHOR)
Zdroj: BMC Cancer. 9/23/2020, Vol. 20 Issue 1, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje